We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

Tim Heffron - Vice President, Discovery Chemistry

Tim Heffron

Vice President, Discovery Chemistry

"Each day we work to extend and improve lives."
17
Years at Genentech
38
Publications at Genentech
2
Awards & Honors

I joined the Discovery Chemistry department at Genentech as a Medicinal Chemist in 2005. I was drawn to Genentech because of the palpable passion and energy for science and discovering medicines based on scientific discovery. That passion and energy continues today. I enjoy being part of a group that pursues medicines for many different therapeutic areas, and across different modalities.

Featured Publication

Discovery of Clinical Development Candidate GDC-0084, a Brain Penetrant Inhibitor of PI3K and mTOR.

ACS Med Chem Lett. 2016 Feb 16;7(4):351-6.

Heffron TP, Ndubaku CO, Salphati L, Alicke B, Cheong J, Drobnick J, Edgar K, Gould SE, Lee LB, Lesnick JD, Lewis C, Nonomiya J, Pang J, Plise EG, Sideris S, Wallin J, Wang L, Zhang X, Olivero AG.